{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:07:18Z","timestamp":1781132838670,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["R01MH124465T"],"award-info":[{"award-number":["R01MH124465T"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Of the 8 million people in South Africa living with HIV, 74% of persons living with HIV are on antiretroviral therapy (ART) and 65% are virally suppressed. Detectable viral load results in HIV-associated morbidity and mortality and HIV transmission. Patient barriers to care, such as missed wages, transport costs, and long wait times for clinic visits and ART refills, are associated with detectable viral load. HIV differentiated service delivery (DSD) has simplified ART delivery for clients who achieve viral suppression and engage in care. However, DSD needs adaptation to serve clients who are not engaged in care.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A Sequential Multiple Assignment Randomized Trial will be undertaken in KwaZulu-Natal, South Africa, to test adaptive ART delivery for persons with detectable viral load and\/or who are not engaged in care. The types of differentiated service delivery (DSD) which will be examined in this study are clinic-based incentives, community-based smart lockers, and home delivery. The study plans to enroll up to 900 participants-people living with HIV, eligible for ART, and who are not engaged in care. The study aims to assess the proportion of ART-eligible persons living with HIV who achieve viral suppression at 18 months. The study will also evaluate the preferences of clients and providers for differentiated service delivery and evaluate the cost-effectiveness of adaptive HIV treatment for those who are not engaged in care.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>To increase population-level viral suppression, persons with detectable viral load need responsive DSD interventions. A Sequential Multiple Assignment Randomized Trial (SMART) design facilitates the evaluation of a stepped, adaptive approach to achieving viral suppression with \u201cright-sized\u201d interventions for patients most in need of effective and efficient HIV care delivery strategies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\">ClinicalTrials.gov<\/jats:ext-link>NCT05090150. Registered on October 22, 2021<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13063-022-07025-x","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T03:03:07Z","timestamp":1673924587000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A Sequential Multiple Assignment Randomized Trial of scalable interventions for ART delivery in South Africa: the SMART ART study"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2530-6885","authenticated-orcid":false,"given":"Alastair","family":"van Heerden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Szpiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xolani","family":"Ntinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Celum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"van Rooyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaynab","family":"Essack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruanne","family":"Barnabas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,17]]},"reference":[{"issue":"2","key":"7025_CR1","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S1473-3099(17)30681-3","volume":"18","author":"LE Hermans","year":"2018","unstructured":"Hermans LE, Moorhouse M, Carmona S, et al. Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided south African treatment programmes: a multicentre cohort study. Lancet Infect Dis. 2018;18(2):188\u201397.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"7025_CR2","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1016\/S2352-3018(16)30225-9","volume":"4","author":"G Reniers","year":"2017","unstructured":"Reniers G, Blom S, Calvert C, et al. Trends in the burden of HIV mortality after roll-out of antiretroviral therapy in KwaZulu-Natal, South Africa: an observational community cohort study. Lancet HIV. 2017;4(3):e113\u2013e21.","journal-title":"Lancet HIV"},{"key":"7025_CR3","unstructured":"IN DANGER: UNAIDS Global AIDS Update 2022. Geneva: Joint United Nations Programme on HIV\/ AIDS; 2022."},{"issue":"2","key":"7025_CR4","doi-asserted-by":"publisher","first-page":"17383","DOI":"10.7448\/IAS.15.2.17383","volume":"15","author":"K Kranzer","year":"2012","unstructured":"Kranzer K, Govindasamy D, Ford N, Johnston V, Lawn SD. Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review. J Int AIDS Soc. 2012;15(2):17383.","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"7025_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/13545700802266452","volume":"14","author":"N Nattrass","year":"2008","unstructured":"Nattrass N. Gender and access to antiretroviral treatment in South Africa. Fem Econ. 2008;14(4):19\u201336.","journal-title":"Fem Econ"},{"key":"7025_CR6","doi-asserted-by":"crossref","unstructured":"Nsanzimana S, Kanters S, Remera E, et al. HIV care continuum in Rwanda: a cross-sectional analysis of the national programme. Lancet HIV. 2015;2(5):e208-15.","DOI":"10.1016\/S2352-3018(15)00024-7"},{"issue":"11","key":"7025_CR7","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1097\/QAD.0000000000000721","volume":"29","author":"LF Johnson","year":"2015","unstructured":"Johnson LF, Rehle TM, Jooste S, Bekker LG. Rates of HIV testing and diagnosis in South Africa: successes and challenges. Aids. 2015;29(11):1401\u20139.","journal-title":"Aids"},{"issue":"2","key":"7025_CR8","doi-asserted-by":"crossref","first-page":"e25519","DOI":"10.1002\/jia2.25519","volume":"23","author":"RV Barnabas","year":"2020","unstructured":"Barnabas RV, van Heerden A, McConnell M, et al. Lottery incentives have short-term impact on ART initiation among men: results from a randomized pilot study. J Int AIDS Soc. 2020;23(2):e25519.","journal-title":"J Int AIDS Soc"},{"issue":"9","key":"7025_CR9","doi-asserted-by":"publisher","first-page":"e1002659","DOI":"10.1371\/journal.pmed.1002659","volume":"15","author":"P Geldsetzer","year":"2018","unstructured":"Geldsetzer P, Francis JM, Sando D, et al. Community delivery of antiretroviral drugs: a non-inferiority cluster-randomized pragmatic trial in Dar Es Salaam, Tanzania. PLoS Med. 2018;15(9):e1002659.","journal-title":"PLoS Med"},{"key":"7025_CR10","doi-asserted-by":"crossref","unstructured":"Amstutz A, Brown JA, Ringera I, et al. Engagement in care, viral suppression, drug resistance and reasons for non-engagement after home-based same-day ART initiation in Lesotho: a two-year follow-up of the CASCADE trial. Clin Infect Dis. 2020;71(10):2608-14.","DOI":"10.1093\/cid\/ciz1126"},{"issue":"10","key":"7025_CR11","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/j.1365-3156.2012.03055.x","volume":"17","author":"MP Fox","year":"2012","unstructured":"Fox MP, Larson B, Rosen S. Defining retention and attrition in pre-antiretroviral HIV care: proposals based on experience in Africa. Trop Med Int Health. 2012;17(10):1235\u201344.","journal-title":"Trop Med Int Health"},{"issue":"Suppl 1","key":"7025_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-3156.2010.02508.x","volume":"15","author":"MP Fox","year":"2010","unstructured":"Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Tropical Med Int Health. 2010;15(Suppl 1):1\u201315.","journal-title":"Tropical Med Int Health"},{"issue":"1","key":"7025_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/QAI.0000000000000553","volume":"69","author":"MP Fox","year":"2015","unstructured":"Fox MP, Rosen S. Retention of adult patients on antiretroviral therapy in low- and middle-income countries: systematic review and meta-analysis 2008-2013. J Acquir Immune Defic Syndr. 2015;69(1):98\u2013108.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"7025_CR14","volume-title":"Retention on antiretroviral therapy in South Africa: evidence from a systematic review","author":"S Rosen","year":"2014","unstructured":"Rosen S, Fox MP. Retention on antiretroviral therapy in South Africa: evidence from a systematic review. Johannesburg: HE2RO Policy Brief Number 8, Health Economics and Epidemiology Research Office; 2014."},{"issue":"7","key":"7025_CR15","doi-asserted-by":"publisher","first-page":"e1002874","DOI":"10.1371\/journal.pmed.1002874","volume":"16","author":"MP Fox","year":"2019","unstructured":"Fox MP, Pascoe S, Huber AN, et al. Adherence clubs and decentralized medication delivery to support patient retention and sustained viral suppression in care: results from a cluster-randomized evaluation of differentiated ART delivery models in South Africa. PLoS Med. 2019;16(7):e1002874.","journal-title":"PLoS Med"},{"issue":"Suppl 3","key":"7025_CR16","doi-asserted-by":"publisher","first-page":"S339","DOI":"10.1097\/QAI.0000000000002195","volume":"82","author":"DA Roberts","year":"2019","unstructured":"Roberts DA, Tan N, Limaye N, Irungu E, Barnabas RV. Cost of differentiated HIV antiretroviral therapy delivery strategies in sub-Saharan Africa: a systematic review. J Acquir Immune Defic Syndr. 2019;82(Suppl 3):S339\u2013S47.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"7025_CR17","unstructured":"Bassett IV. Barriers to access to diagnosis and treatment. IAS 2019. Mexico: The International AIDS Society; 2019."},{"issue":"9","key":"7025_CR18","doi-asserted-by":"publisher","first-page":"e25176","DOI":"10.1002\/jia2.25176","volume":"21","author":"L Cluver","year":"2018","unstructured":"Cluver L, Pantelic M, Toska E, et al. STACKing the odds for adolescent survival: health service factors associated with full retention in care and adherence amongst adolescents living with HIV in South Africa. J Int AIDS Soc. 2018;21(9):e25176.","journal-title":"J Int AIDS Soc"},{"issue":"5","key":"7025_CR19","doi-asserted-by":"publisher","first-page":"e212","DOI":"10.1016\/S2352-3018(16)00020-5","volume":"3","author":"RV Barnabas","year":"2016","unstructured":"Barnabas RV, van Rooyen H, Tumwesigye E, et al. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda. Lancet HIV. 2016;3(5):e212\u201320.","journal-title":"Lancet HIV"},{"key":"7025_CR20","unstructured":"Asiimwe S, Van Rooyen H, Schaafsma T, et al. Community-based HIV testing and assessment for same-day ART reaches men for HIV care. AIDS 2018. Amsterdam: The HIV Prevention Trials Network; 2018."},{"issue":"7","key":"7025_CR21","doi-asserted-by":"publisher","first-page":"e0219826","DOI":"10.1371\/journal.pone.0219826","volume":"14","author":"S Dave","year":"2019","unstructured":"Dave S, Peter T, Fogarty C, Karatzas N, Belinsky N, Pant PN. Which community-based HIV initiatives are effective in achieving UNAIDS 90-90-90 targets? A systematic review and meta-analysis of evidence (2007-2018). PLoS One. 2019;14(7):e0219826.","journal-title":"PLoS One"},{"key":"7025_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev-clinpsy-032511-143152","volume":"8","author":"H Lei","year":"2012","unstructured":"Lei H, Nahum-Shani I, Lynch K, Oslin D, Murphy SA. A \u201cSMART\u201d design for building individualized treatment sequences. Annu Rev Clin Psychol. 2012;8:21\u201348.","journal-title":"Annu Rev Clin Psychol"},{"issue":"Suppl 1","key":"7025_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/10810730490271449","volume":"9","author":"EM Rogers","year":"2004","unstructured":"Rogers EM. A prospective and retrospective look at the diffusion model. J Health Commun. 2004;9(Suppl 1):13\u20139.","journal-title":"J Health Commun"},{"issue":"4","key":"7025_CR24","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1037\/a0029372","volume":"17","author":"I Nahum-Shani","year":"2012","unstructured":"Nahum-Shani I, Qian M, Almirall D, et al. Experimental design and primary data analysis methods for comparing adaptive interventions. Psychol Methods. 2012;17(4):457\u201377.","journal-title":"Psychol Methods"},{"issue":"1","key":"7025_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2307\/2531248","volume":"42","author":"SL Zeger","year":"1986","unstructured":"Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42(1):121\u201330.","journal-title":"Biometrics"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-07025-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-07025-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-07025-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T21:07:42Z","timestamp":1701724062000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-07025-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7025"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-07025-x","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,17]]},"assertion":[{"value":"8 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was received from all relevant authorities in South Africa including the Human Sciences Research Councils Research Ethics Committee (REC 6\/19\/05\/21) and the Department of Health (KZ_202108_020). In the USA, IRB approval was obtained (STUDY00013492). Written informed consents to screen and enrol will be obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable\u2014no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. Informed consent materials are from the corresponding author on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare that they have no competing interests","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"32"}}